Lynozyfic Approved In European Union For Treatment Of Relapsed/Refractory Multiple Myeloma
Reuters
04-28
April 28 (Reuters) - Regeneron Pharmaceuticals Inc :: *LYNOZYFIC™ (LINVOSELTAMAB) APPROVED IN THE EUROPEAN UNION FOR THE TREATMENT OF RELAPSED/REFRACTORY MULTIPLE MYELOMA